SDIX
SDIX is a leading immuno-solutions company specializing in high-quality antibody-based solutions for the IVD, anatomic pathology, biotechnology, and pharmaceutical markets. With over 30 years of experience, SDIX develops innovative and results-oriented products, including IHC antibodies and IVD reagents, to help customers achieve their diagnostic and commercialization objectives.
As a wholly owned subsidiary of OriGene Technologies, SDIX offers large-scale GMP antibody production in the U.S., with facilities in Delaware and Maine. Their commitment to performance, specificity, and quality ensures that customers receive better antigens, better antibodies, and better assays for a healthier tomorrow.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.